Patent: 10,660,941
✉ Email this page to a colleague
Summary for Patent: 10,660,941
| Title: | Orally administrable pharmaceutical preparation containing protein |
| Abstract: | An orally administrable pharmaceutical preparation containing a protein. More particularly, an orally administrable pharmaceutical preparation including a protein loaded on metal oxide nanoparticles and an amino acid; wherein the amino acid forms an adduct with the protein loaded on metal oxide nanoparticles. An process for the production of the afore-mentioned orally administrable pharmaceutical preparation is also disclosed. |
| Inventor(s): | Bellare; Jayesh (Mumbai, IN), Dwivedi; Neelam Vishwanath (Mumbai, IN), Adhimoolam; Arunagirinathan Manickam (Chennai, IN), Sharma; Somesh Datt (Los Altos, CA) |
| Assignee: | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) |
| Application Number: | 15/999,777 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,660,941
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | October 28, 1982 | ⤷ Start Trial | 2037-02-17 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | December 29, 2015 | ⤷ Start Trial | 2037-02-17 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | August 06, 1998 | ⤷ Start Trial | 2037-02-17 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | March 31, 1994 | ⤷ Start Trial | 2037-02-17 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | May 25, 2018 | ⤷ Start Trial | 2037-02-17 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
